Literature DB >> 3898053

Is there an ideal antiarrhythmic drug? A review--with particular reference to class I antiarrhythmic agents.

K A Muhiddin, P Turner.   

Abstract

Mesh:

Substances:

Year:  1985        PMID: 3898053      PMCID: PMC2418373          DOI: 10.1136/pgmj.61.718.665

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  83 in total

1.  Procainamide induction of a systemic lupus erythematosus-like syndrome. Presentation of six cases, review of the literature, and analysis and followup of reported cases.

Authors:  E L Dubois
Journal:  Medicine (Baltimore)       Date:  1969-05       Impact factor: 1.889

2.  Drugs and the heart. IV. Antiarrhythmic agents.

Authors:  L H Opie
Journal:  Lancet       Date:  1980-04-19       Impact factor: 79.321

3.  Clinical pharmacology of antiarrhythmic drugs: a review and overview, part II.

Authors:  B N Singh; Y W Cho; H P Kuemmerle
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1981-05

4.  Disopyramide-induced QT prolongation and ventricular tachyarrhythmias.

Authors:  N Riccioni; M Castiglioni; C Bartolomei
Journal:  Am Heart J       Date:  1983-05       Impact factor: 4.749

5.  Correlation between serum concentration and pharmacological effect on atrioventricular conduction time of the antiarrhythmic drug propafenone.

Authors:  K Keller; G Meyer-Estorf; O A Beck; H Hochrein
Journal:  Eur J Clin Pharmacol       Date:  1978-03-17       Impact factor: 2.953

6.  Adverse effects of disopyramide (Norpace): toxic interactions with other antiarrhythmic agents.

Authors:  G Ellrodt; B N Singh
Journal:  Heart Lung       Date:  1980 May-Jun       Impact factor: 2.210

7.  The antiarrhythmic effect of intravenous disopyramide in an open study.

Authors:  A M Tonkin; W F Heddle; J H Bett; R J Kemp; G L Donnelly; G I Nelson; E Manolas; J G Sloman
Journal:  Aust N Z J Med       Date:  1982-08

8.  Pharmacokinetics of lorcainide, a new antiarrhythmic drug, in patients with cardiac rhythm disorders.

Authors:  P Somani
Journal:  Am J Cardiol       Date:  1981-07       Impact factor: 2.778

9.  The effect of amiodarone, a new anti-anginal drug, on cardiac muscle.

Authors:  B N Singh; E M Vaughan Williams
Journal:  Br J Pharmacol       Date:  1970-08       Impact factor: 8.739

10.  Apparent quinidine-induced digoxin toxicity after withdrawal of pentobarbital: a case of sequential drug interactions.

Authors:  D J Chapron; D Mumford; G I Pitegoff
Journal:  Arch Intern Med       Date:  1979-03
View more
  2 in total

Review 1.  [Class I antiarrhythmic drugs: mechanisms, contraindications, and current indications].

Authors:  C Pott; D G Dechering; A Muszynski; S Zellerhoff; A Bittner; K Wasmer; G Mönnig; L Eckardt
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2010-12

2.  Exploration of Mechanisms of Sacubitril/Valsartan in the Treatment of Cardiac Arrhythmias Using a Network Pharmacology Approach.

Authors:  Yu Zhou; Shibao Rui; Shengxin Tang; Changlin Ju
Journal:  Front Cardiovasc Med       Date:  2022-04-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.